Bioharvest Sciences BHST
NASDAQ BHST
$1.67 0.00 (-0.12%)
As of: Oct 22, 2026 · 3:58 PM EDT

Bioharvest Sciences (BHST) Non Operating Interest Expenses (2024 - 2025)

Updated

Analysis

Bioharvest Sciences (BHST) Non Operating Interest Expenses (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Bioharvest Sciences 31.11 Mn -37.25 Mn 5.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.53 Mn
Jun 30, 2025 638,000.00
Mar 31, 2025 581,000.00
Sep 30, 2024 587,000.00
Jun 30, 2024 53,000.00
API Access

Bioharvest Sciences Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BHST&period=max&api_key=YOUR_API_KEY